Abstract
Multipoint pacing (MPP) may improve outcomes of patient undergoing cardiac resynchronisation therapy (CRT), however the impact on projected battery longevity (PBL) in a randomised controlled trial (RCT) is unclear. The MPP VARR study aims to determine if MPP results in a greater response in patients receiving CRT with MPP (MPP-ON) when compared to conventional CRT (MPP-OFF).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
